Back to search results

WIM Exosuit Wearable Soft Robot for Walking Activity

This study is testing a soft, wearable robot called the WIM Robotic Exoskeleton, which helps power your hips, to see if it can improve walking. It's designed for people who have had a stroke, Parkinson's disease, multiple sclerosis, or healthy adults over 65. Healthy individuals can also join to help optimize the device. Researchers will measure how far you can walk in six minutes and your metabolic cost (how much energy your body uses) to see if the WIM Robotic Exoskeleton is helpful. The study plans to enroll 20 participants, but its current status is unclear.

Study design
This is an interventional study, meaning participants will receive a specific intervention. It plans to enroll 20 participants.
What's involved
You would participate in a single session where your walking ability and metabolic cost are measured.
Compensation
Not stated in the trial record.
Follow-up
Measurements are taken at a single session, so there is no extended follow-up period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07061691

WIM Exosuit Wearable Soft Robot for Enhancing Walking Activity

Recruiting
NAAges 18–89InterventionalTreatment
Shirley Ryan AbilityLab
~20 participants
Updated 2025-08-29 on ClinicalTrials.gov
What's tested:WIM Robotic Exoskeleton

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
6-minute walk test
Measured over Baseline (Single-session)
+1 more outcome measured

Conditions

Stroke
Healthy

Explore related trials

HealthyMultiple SclerosisParkinson DiseaseStroke

Where it's being run

1 sites across 1 states
Illinois1

Who to contact

Katelyn Aragon
[email protected]
312-238-8312
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

\- Be at least 6 months post-stroke, have a diagnosis of Parkinson's, have a diagnosis of multiple sclerosis, or an adult older than 65 with no known neurological diagnoses.
Age: 18-89 years of age
For stroke, Parkinson's, multiple sclerosis, or older adult participants, must have adequate cognitive function (MMSE score \>17)
Ability to walk at least 10 meters with maximum of 1 person assist
Able to safely fit into the WIM exosuit, which is confirmed via an in-person fitting..

Exclusion

\- \<90 days post major orthopedic surgery (i.e. hip, knee, and/or ankle joint replacement.)
\< 6 months post CABG or cardiac valve procedure
Any skin irritations / conditions that may preclude a participant from tolerating the use of the exosuit.
Severe osteoporosis, defined as osteoporosis that has been diagnosed and a participant's doctor has recommended pharmacologic treatment, or there is both a history of osteoporosis and a history of fractures.
Serious cardiac conditions, such as hospitalization for myocardial infarction or heart surgery within 3 months, history of congestive heart failure, documented serious and unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during activities of daily living.
Pregnancy
Uncontrolled hypertension (resting systolic blood pressure greater than or equal to 150, or resting diastolic pressure greater than or equal to 90.) If a participant demonstrates a BP greater than these values, then the participant will sit quietly for 5 mins, and then be re-checked. If the BP values remain over those thresholds, then the participant will be excluded. Individuals in such situations may return to be re-screened for participation after they follow up with their physician and the hypertension is better controlled.
Lower extremity fracture, either currently or within the past 6 months.
Modified Ashworth Spasticity (MAS) scores of ≥ 3 in hip flexors or extensors, if the participant is post-stroke or multiple sclerosis.
Pre-existing neurological disorders such as amyotrophic lateral sclerosis (ALS), dementia
History of major head trauma, lower extremity amputation, non-healing ulcers of a lower extremity, ongoing active infections, legal blindness, or a history of significant psychiatric illness.

What this trial measures

  • 6-minute walk testBaseline (Single-session)

    Primary outcome for Optimization aim of study.

  • Metabolic CostBaseline (single session)

    Primary outcome for Optimization aim of study. Data collected using Cosmed K5 Metabolic Unit